Stay updated on FLYSYN-101 Clinical Trial in MRD Positive AML

Sign up to get notified when there's something new on the FLYSYN-101 Clinical Trial in MRD Positive AML page.
Latest website image capture
Clouds background image

Latest updates to the FLYSYN-101 Clinical Trial in MRD Positive AML page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.8%
    Check dated 2025-04-30T14:19:30.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2025-04-23T12:30:54.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has removed significant details regarding a clinical study on the Fc-optimized antibody FLYSYN, including study design, patient cohorts, and inclusion/exclusion criteria, while adding version information.
    Difference
    32%
    Check dated 2025-04-16T10:16:20.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.4%
    Check dated 2025-04-09T05:10:19.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-25T13:24:08.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-11T03:54:35.000Z thumbnail image

Stay in the know with updates to FLYSYN-101 Clinical Trial in MRD Positive AML

Enter your email address, and we'll notify you when there's something new on the FLYSYN-101 Clinical Trial in MRD Positive AML page.